Diagnostic accuracy of fine needle aspiration of the thyroid: a comparative study of the technique with and without ultrasonography
Keywords:
thyroid gland nodules, nodular goiter, thyroid needle aspiration, differentiated thyroid cancer, cytopathologyAbstract
Background and aim of the work: Fine needle aspiration biopsy (FNAB) of thyroid is an indispensable procedure in the evaluation of patients with thyroid nodules. The aim of this study was to evaluate the benefit of ultrasonography (USG)-guided FNAB compared to the conventional method. Methods: In this comparative cross-sectional study FNAB samples were collected in 1984 (G1) and 2011 (G2). In G1 (113 patients) FNAB was performed by palpation, and in G2 (1,049 patients) it was USG-guided. Statistical analysis included sensitivity, specificity, positive/negative predictive value, and likelihood ratio. Associations were considered statistically significant when p-value≤0.05. Results: The percentage of unsatisfactory material was 24% in G1 and 7.8% in G2. The sensitivity/specificity in G1 were 40% / 71%, and in G2, 83% / 94.7%. In G2, it was possible to select 77.7% of malignant nodules for surgery, while in G1 only 10%. In G2, the frequency of malignancies was similar between nodules smaller and larger than 1cm (Fisher’s exact test p-value=0.33). Conclusions: Our data confirm that FNAB is a valid technique for screening malignant thyroid nodules, especially when guided by USG. Since subcentimetric nodules harbor malignancy as much as larger nodules, we recommend performing FNAB in all thyroid nodules, regardless of size.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.